In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

S Laukkanen, T Grönroos, P Pölönen, H Kuusanmäki, J Mehtonen, J Cloos, G Ossenkoppele, B Gjertsen, B Øystein, C Heckman, M Heinäniemi, M Kontro, O Lohi

Research output: Contribution to journalArticleScientificpeer-review

10 Citations (Scopus)
Original languageEnglish
Article numbere604
Pages (from-to)e604
JournalBlood Cancer Journal
Issue number9
Publication statusPublished - 2017
Publication typeA1 Journal article-refereed

Publication forum classification

  • Publication forum level 1

Cite this